Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|April 10, 2017
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironmentGülçin Gezgin, Mehmet Dogrusöz, T Huibertus van Essen, et al.
Chemico-Biological Interactions|November 13, 2020
The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infectionsNeil D Christensen, Kun-Ming Chen, Jiafen Hu, et al.
Scientific Reports|December 8, 2016
FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell LinesJoshua I Warrick, Vonn Walter, Hironobu Yamashita, et al.
Elife|February 21, 2023
Orai3 and Orai1 mediate CRAC channel function and metabolic reprogramming in B cellsScott M Emrich, Ryan E Yoast, Xuexin Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2025
PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammationArrienne B Butic, Elia Afanasiev, Samantha A Spencer, et al.
Redox Biology|December 5, 2018
GPx3 supports ovarian cancer progression by manipulating the extracellular redox environmentBeth L Worley, Yeon Soo Kim, Jennifer Mardini, et al.
Journal of Critical Care|April 19, 2021
Bacteremia in critically ill immunocompromised patients with acute hypoxic respiratory failure: A post-hoc analysis of a prospective multicenter multinational cohortAndry Van de Louw, Jordi Rello, Ignacio Martin-Loeches, et al.
Oral Oncology|August 13, 2018
Frequent HPV-independent p16/INK4A overexpression in head and neck cancerMatt Lechner, Ankur R Chakravarthy, Vonn Walter, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023Monika Joshi, Leonard Tuanquin, Junjia Zhu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2025
Differential hepatic activation of mouse and human peroxisome proliferator-activated receptor-α by perfluorohexane sulfonateYahya Khan, Annalee M Schmidt, Kyle J Oldro, et al.
Pageof 11